MK-4827 Racemate

CAS No. 1038915-75-1

MK-4827 Racemate( Niraparib Racemate | 2-(4-piperidin-3-ylphenyl)indazole-7-carboxamide )

Catalog No. M27657 CAS No. 1038915-75-1

MK-4827 Racemate is a selective PARP1 and PARP2 inhibitor with IC50s of 3.8 nM and 2.1 nM, respectively, over 330-fold selectivity for PARP3, V-PARP and Tank1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 57 Get Quote
5MG 80 Get Quote
10MG 140 Get Quote
25MG 267 Get Quote
50MG 466 Get Quote
100MG 628 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MK-4827 Racemate
  • Note
    Research use only, not for human use.
  • Brief Description
    MK-4827 Racemate is a selective PARP1 and PARP2 inhibitor with IC50s of 3.8 nM and 2.1 nM, respectively, over 330-fold selectivity for PARP3, V-PARP and Tank1.
  • Description
    MK-4827 Racemate is a selective PARP1 and PARP2 inhibitor with IC50s of 3.8 nM and 2.1 nM, respectively, over 330-fold selectivity for PARP3, V-PARP and Tank1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Niraparib Racemate | 2-(4-piperidin-3-ylphenyl)indazole-7-carboxamide
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    DNA/RNA Synthesis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1038915-75-1
  • Formula Weight
    320.396
  • Molecular Formula
    C19H20N4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC(=O)c1cccc2cn(nc12)-c1ccc(cc1)C1CCCNC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.James D Thorpe, et al. Mechanochemical Synthesis of Short DNA Fragments. Chemistry. 2020 Jul 22;26(41):8857-8861.
molnova catalog
related products
  • Rucaparib Camsylate

    Rucaparib Camsylate is a PARP inhibitor (PARP1,Ki of 1.4 nM). Rucaparib Camsylate also displays binding affinity to eight other PARP domains. Rucaparib is the most effective PARP inhibitor in enzyme assays (Ki: 1.4 nM). Rucaparib inhibits PARP-1 activity by 97.1% at a concentration of 1 μM in permeabilized D283Med cells.

  • Talazoparib tosylate

    Talazoparib tosylate is a novel and potent PARP1/2 (n IC50: 0.57 nM for PARP1).

  • AZD-9574

    AZD-9574 is a selective inhibitor of PARP1 at the sites of SSBs. AZD-9574 exhibits anti-cancer activities and can be used in studies about HRD+ breast cancer and advanced solid malignancies.